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Abstract
Background: Shoulder pain is a common problem in the general population and is responsible for prolonged
periods of disability, loss of productivity, absence from work and inability to carry out household activities. Rotator
cuff problems account for up to 70% of shoulder pain problems and are the third most prevalent musculoskeletal
disorder after those occurring in the lower back and neck. Rotator cuff surgery has high failure rates (25–50% within
12 months), and as a result, there is a pressing need to improve the outcome of rotator cuff surgery. Patch augmented
surgery for rotator cuff repairs has recently been developed and is increasingly being used within the UK National Health
Service. Patch augmented surgery could lead to a dramatic improvement in patient and surgical outcomes, but its
clinical and cost effectiveness needs rigorous evaluation. The existing evidence on the use of patches may be at risk of
bias as currently only a small number of single-centre comparative studies appear to have been carried out. Additionally,
it is unclear for which patches a clinical study (comparative and non-comparative) has been conducted. This paper
outlines the protocol for a systematic review intended to summarise the best available clinical evidence and will indicate
what further research is required.
Methods: Electronic databases (Medline, Embase and Cochrane) will be systematically searched between April 2006 and
the present day for relevant publications using a specified search strategy, which can be adapted for the use in multiple
electronic databases, and inclusion criteria. Screening of both titles and abstracts will be done by two independent
reviewers with any discrepancies resolved by a third independent reviewer. Data extraction will include information
regarding the type of participants, type of intervention and outcomes including but not limited to shoulder-specific
function and pain scores, patch-related adverse events and type of study. The results will be summarised in a narrative
review where qualitative analysis is not possible.
Discussion: This review aims to collate the current evidence base regarding the use of patches to augment rotator cuff
repair. The results of this review will help to develop, using consensus methods, the design of a definitive randomised
trial assessing the clinical and cost-effectiveness of a patch to augment surgical repair of the rotator cuff that is both
acceptable to stakeholders and is feasible.
Systematic review registration: CRD42017057908
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Background
Shoulder pain is a common problem in the general
population and is responsible for prolonged periods of
disability, loss of productivity, absence from work and
inability to carry out household activities. Rotator cuff
problems relate to the tendons and muscles surrounding
the shoulder joint. They account for up to 70% of shoul-
der pain problems and are the third most prevalent
musculoskeletal disorder after those occurring in the
lower back and neck [1].
A challenging but common rotator cuff problem is a
rotator cuff tendon tear, found in about 25% of people
aged 70 and above [1]. Symptoms include pain, weak-
ness, lack of shoulder mobility and sleep disturbance.
Initial management is conservative and includes rest
with simple pain management using paracetamol and
non-steroidal anti-inflammatory drugs. Approximately
40% of patients will continue to experience pain despite
conservative management, and many will require surgery
to repair the tear [2, 3].
Rotator cuff surgery has high failure rates (25–50%
within 12 months) [4, 5] and is expensive, invasive and in-
convenient to patients. Re-operation is also sometimes ne-
cessary. Around 9,000 rotator cuff repairs are performed
each year in the National Health Service (NHS) in England,
at a cost of £6,628 per operation (£60 million per year),
and this number is still growing [6, 7]. There is a pressing
need to improve the outcome of rotator cuff surgery [8].
Various surgical approaches have been tried unsuc-
cessfully to improve the outcome of rotator cuff repair
[6, 9]. Patch augmented surgery for rotator cuff repair
has recently been developed and anecdotally would ap-
pear to be increasingly used within the UK NHS. Using
a patch to provide a support structure or ‘scaffold’ for
the repair, to improve the fixing of the tendon to the
bone and tendon healing, has provided promising results
[10–12]. The patch is surgically sutured on top of the
tendon-to-bone repair to strengthen the repair and aid
the healing process, thereby reducing the likelihood of
failure and improving patient outcomes [13].
Patches have been made using different materials (hu-
man/animal heart, skin or intestine tissue, and completely
synthetic materials) and processes (e.g. woven or mesh ap-
proaches) and to different sizes. Some have been designed
specifically for rotator cuff repair surgery or can be tai-
lored in size and shape for use in this operation, whereas
others were developed for other soft-tissue contexts (e.g.
anterior cruciate ligament reconstruction in the knee or
for hernia repair). They can also be designed to be absorb-
able, avoiding the possibility of later surgical complica-
tions or surgical removal [14]. A number of pre-clinical
(in vivo and in vitro mechanical properties) studies have
been conducted, evaluating various patches, which have
had positive findings [15].
Patches differ in how they respond to tendon tissue and
their mechanical properties [16]. Recent advances include
the development of electrospun materials [12] and explor-
ation of the concurrent use of growth factors. Electrospun
materials have a structure that closely resembles the sur-
rounding tissue, and they provide biological cues to en-
courage cell growth and tissue healing [12]. The aim of
these and other biomimetic materials is to avoid adverse
immunological responses, which some tissue-based
patches have provoked [17]. Augmenting surgical repair
with a patch may also enable the repair of tears that are
currently considered unrepairable [10, 14, 18–20].
There is a pressing need to improve the surgical op-
tions available for rotator cuff repairs in order to im-
prove tendon healing and patient outcomes [8]. Various
other approaches have been attempted to improve the
outcome of this surgery without success. Innovative sur-
gical intervention requires evaluation for efficacy and
safety. Whilst some studies have been conducted on the
use of a patch for rotator cuff repair, there would appear
to have only been a small number of single-centre com-
parative studies (predominantly based in North Amer-
ica) carried out [10, 17, 21, 22]; additionally, they seem
to have evaluated only a subset of the available patches.
Patch augmented surgery could lead to a dramatic im-
provement in patient and surgical outcomes, but the
clinical and cost-effectiveness of the intervention needs
rigorous evaluation. This protocol outlines the objectives
of the systematic review and the methods used to iden-
tify the relevant current evidence base. It is in line with
the reporting standards set out in the PRISMA-P check-
list [see Additional file 1: PRISMA-P checklist].
Objectives
The aim of this systematic review is to identify and crit-
ically appraise studies reporting on the clinical use of
patch augmented surgical repair of a rotator cuff tear in
terms of clinical effectiveness and safety. There is scope
within this systematic literature review to also identify
the most clinically effective and safe candidate patches
for use in a future definitive randomised controlled trial
(RCT).
Methods/design
Criteria for considering studies for this systematic review
In order to search for and identify the relevant studies, a
scoping search was initially undertaken to inform the
definitions used in the final search strategy and corre-
sponding inclusion criteria. The finalised criteria applied
to address the research question are as follows:
Types of participants
Studies evaluating adults (≥ 18 years) who require surgi-
cal repair of a rotator cuff tear will be included. No
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restrictions will be applied to comorbidities (diabetes,
heart disease etc.), the type of rotator cuff tear (partial or
full thickness), tendon involvement (supraspinatus, infra-
spinatus, teres minor or subscapularis) or based on
whether the tear is a first occurrence or recurrence. Pa-
tients receiving surgical treatment for additional pathology
such as a fracture or osteoarthritis, alongside a rotator cuff
tear, will not be excluded, providing the principal use of
the patch is for the repair of the rotator cuff tear.
Studies where there is a mixed population of patients re-
ceiving a patch for rotator cuff repair or another indica-
tion such as patella or bicep repairs will be excluded if the
results are not reported for each individual indication.
Types of intervention/comparators
All studies where at least one treatment arm includes the
use of either commercially or non-commercially available
patches to augment rotator cuff surgery will be included.
Studies may have a single intervention group or may have
two or more interventions groups. There is no restriction
with regard to any comparison group (e.g. a study could
compare patch A vs patch B, or a patch versus a drug or
other kind of intervention). For the purposes of this sys-
tematic review, a patch is defined as an implantable hu-
man, synthetic, or animal material which is used with the
aim of improving tissue healing and/or patient outcome
via some form of mechanical support. There will be no ex-
clusions based on the type (synthetic or non-synthetic) or
the source of the patch (e.g. human, porcine, bovine or
equine); studies of suture and anchors used in isolation
will not be eligible for inclusion. There will be no restric-
tion on the type of surgery received or the grade or experi-
ence of the surgeon completing the surgery.
Studies reporting on non-relevant interventions only,
such as drug therapy or physiotherapy, will be excluded;
however, these interventions may, as noted above, be used
in a comparator group or used in addition to a patch in
the same intervention group within an eligible study.
Types of outcome measures
There will be no exclusions made based on the out-
comes reported in the identified studies. All outcomes at
all time points, regardless of follow-up, will be of interest
to this review.
The primary outcomes of interest include, but are not
limited to:
(i) Shoulder-specific function and pain scores
Measured using a validated scale such as Oxford Shoul-
der Score (OSS), American Shoulder and Elbow Surgeon
Score (ASES), Disabilities of the Arm Shoulder and Hand
(DASH) questionnaire, Constant scale, PENN shoulder
score, Shoulder Pain and Disability Index (SPADI), Simple
Shoulder Test (SST) or University of California at Los
Angeles scale (UCLA).
(ii) Patch-related adverse events (AEs)
Patch-related adverse events whether confirmed as
due to the patch or only suspected to be (e.g. severe im-
mune responses).
The secondary outcomes will include but not be re-
stricted to the following:
(iii)Shoulder pain outcomes
Single-item shoulder pain measures to be assessed by
validated assessment tools such as the visual analog scale
(VAS), Likert pain scale and other validated or non-vali-
dated dichotomous, categorical or ordinal assessments
or patient-reported outcomes (PROs).
(iv)Health-related quality of life
Including but not limited to overall health-related qual-
ity of life (HRQoL) as assessed by EuroQoL-5D (EQ-5D),
Short Form-36 (SF36) and Health Utilities Index (HUI).
Other secondary outcomes include:
Recurrence of rotator cuff tear and failure to heal
assessed radiographically, revision rates of the surgery,
time to surgical revision and patient satisfaction as de-
fined by the included studies.
Types of studies
This review will consider all relevant randomised con-
trolled trials (RCTs); however, due to the low use of patch
augmented surgeries in practice, there is a paucity of such
studies. Therefore, in addition to RCTs, the review will
also include non-randomised studies (comparative and
single intervention group) involving ≥ 5 patients. No lan-
guage restrictions will be applied, and methods of transla-
tion will be explored for any non-English included studies
that are identified.
In vitro and animal studies will be excluded in
addition to review articles, editorials and single case
studies. Initial scoping searches did not identify any eco-
nomic evaluations relating to patch use in shoulder aug-
mentation and therefore will not be included for the
purposes of this systematic review. Related economic
evaluations will be flagged summarised narratively.
Search methods for the identification of studies
A search strategy was developed [see Additional file 2:
Embase search strategy] in Embase and was adapted for
other electronic databases. The searches will be con-
ducted between the dates of April 2006 to the present
day, as a previous Cochrane review [9] has identified all
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relevant key publications prior to April 2006. The fol-
lowing electronic databases will be searched via the
OVID and Cochrane Library platforms using the prede-
fined search strategy:
(i) The Cochrane Library, incorporating:
 Cochrane Central Register of Controlled Trials
(CENTRAL)
 Cochrane Database of Systematic Reviews
 Database of Abstracts of Reviews of Effects
(DARE)
 The Health Technology Assessment Database
 NHS Economic Evaluation Database (NHS EED)
(ii) Ovid MEDLINE(R) In-Process & Other Non-Indexed
Citations and Ovid MEDLINE(R), 1946 to present.
(iii)Ovid Embase, 1980 to present
Reference lists of included studies and relevant system-
atic reviews identified from the Cochrane database of sys-
tematic reviews, DARE and the health technology
assessment database will be scanned in addition to the ref-
erence list of the previously identified Cochrane review [9],
and one unpublished and two published systematic reviews
assessing patch augmented rotator cuff surgery [11, 23]
that were identified during scoping searches.
Other resources will include contacting experts known
to have an interest in using patches to augment surgery,
contacting authors of key studies already identified dur-
ing scoping searches, requesting information of relevant
research being conducted by the companies working to
produce patches and using the surveys developed and
distributed as part of the Patch Augmented Rotator Cuff
Surgery (PARCS) feasibility study.
Electronic trial registries and regulatory body websites
will also be searched to identify any relevant ongoing
clinical studies, new systematic reviews or health tech-
nology assessments involving patch augmented rotator
cuff surgery, these sources will include:
(i) The World Health Organization (WHO) network of
primary registries (which includes the ISRCTN.org,
EU Clinical Trials Register and Australian New
Zealand Clinical Trials Registry)
(ii) Clinicaltrials.gov
(iii)PROSPERO registry
(iv)Centre for Reviews and Dissemination (CRD) database
(v) Medicines and Healthcare products Regulatory
Agency (MHRA)
(vi) Food and Drug Administration (FDA) agency
Selection of studies
Two researchers will screen all titles and abstracts identi-
fied from the search strategy independently. Full reports
will be obtained if the initial screening indicates that the
identified studies are potentially relevant. Full reports that
meet the inclusion criteria will be included in the review.
Reasons for exclusion will be recorded at each stage and
detailed in a PRISMA (Preferred Reporting Items for Sys-
tematic Reviews and Meta-Analyses) flow diagram. A
third independent reviewer will help to resolve any dis-
crepancies or disagreements if they arise.
Data extraction and management
A standard data extraction table will be used to extract
relevant data under key headings such as study design,
patient population, baseline characteristics and surgical
characteristics such as the technique and surgeon con-
ducting the intervention, the type of intervention re-
ceived and all primary and secondary outcomes of the
included studies.
Data for relevant outcomes will be extracted where
available, and an attempt will be made to contact au-
thors of studies to obtain additional or missing data.
Assessment of risk of bias in included studies
The risk of bias will be assessed by two independent re-
viewers (NN, MB). Any discrepancies will be discussed with
a third reviewer (GG) and resolved based on unanimous
decision. RCTs will be assessed using the tool provided by
the Cochrane Collaboration [24]. It assesses studies accord-
ing to six pre-defined domains: selection bias, performance
bias, detection bias, attrition bias, reporting bias and other
bias. Each domain will be rated as a ‘low’, ‘high’ or an ‘un-
clear’ risk of bias before assessing the study as a whole.
Non-randomised comparative studies will be assessed
using the ROBINS-I tool which is based on the
Cochrane risk of bias tool and was developed by Sterne
et al. [25]. The ROBINS-I tool assesses bias due to con-
founding factors, bias in the selection of the participants
into the study, bias in the classification of the interven-
tions, bias due to departures from the intended interven-
tions, bias due to missing data, bias in the measurement
of the outcomes and bias in the selection of the reported
result. Each domain obtains a risk of bias judgement (no
information or low, moderate, serious or critical risk of
bias) followed by an overall judgement of bias based on
the responses from the signalling questions within each
domain [25].
Single-arm studies will not be quality assessed but will
be characterised according to key features, such as size,
patient group, patches used, outcomes collected and the
nature of the follow-up.
Evidence synthesis and reporting
A scoping search identified a paucity of data, with few
comparative studies conducted to date exploring the types
and ranges of patches available, in the specific patient
population.
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Statistical heterogeneity will be quantified with the I2
and τ statistics [24] and reasons explored as able. Small
study biases will be explored using funnel plots if there
are sufficient studies (10 or more) [24].
If a meta-analysis of the randomised comparative stud-
ies is possible, we will use a random effects method in
Stata version 14.0 using the metan command. Sensitivity
analyses will assess differences associated with study de-
sign and patient population where feasible. Data will be
analysed on a intention to treat basis without imput-
ation of missing data where possible. Given the nature
of the comparison, no cluster randomised nor cross-over
trials are anticipated.
It is unlikely that a meta-analysis can be performed
given the anticipated relatively low number of comparative
studies and differences in methodology; in this circum-
stance, the methods and results of the systematic review
will be written up in a qualitative manner. A narrative
summary of the evidence will be produced and where ap-
propriate tables will report the study design, patient popu-
lation, intervention details and outcomes for each patch
identified in the review. An overall comparison of the use
versus non-use of patch augmentation will be carried out
if possible. Evidence will be sub-grouped according to
patch type.
Economic and cost evaluations will be narratively
summarised.
Discussion
There is a pressing need to improve the surgical options
available for rotator cuff repairs in order to improve ten-
don healing and patient outcomes. Evidence on the use
of patches is limited and only covers a subset of those
patches available as only a small number of comparative
studies have been completed. The main aim of this re-
view is to collate the current evidence base regarding the
use of patches to augment rotator cuff surgery. This in
turn will help to identify those patches frequently used
in practice and help assess the study designs used in pre-
vious and ongoing clinical trials. The results of this re-
view will help to develop, using consensus methods, the
design of a definitive randomised trial assessing the ef-
fectiveness and cost-effectiveness of a patch to augment
surgical repair of the rotator cuff that is both acceptable
to stakeholders and is feasible.
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